Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jonsson Comprehensive Cancer Center
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women 18 years and older with non-metastatic hormone receptor (ER and/or PR) positive breast cancer who are eligible for and planning on starting treatment with an AI within one month of signing consent.
Postmenopausal, defined as at least one of the following: a) amenorrhea for at least 12 months b) prior bilateral oophorectomy at least 2 years prior to trial registration.
You may not be if
History of autoimmune connective tissue disease, such as rheumatoid arthritis, lupus, or other autoimmune conditions affecting joints.
Treatment with steroid (for any condition, except for chemotherapy premedication) within 30 days of trial registration.
Prior treatment with an AI (patients previously or currently on tamoxifen are eligible as long as patients are off tamoxifen for 2 weeks prior to baseline blood draw)
Active or ongoing infection
Known metastatic disease
Known history of HIV or hepatitis infections
Ongoing radiation therapy (radiation must have been completed 2 weeks prior to starting treatment with an AI)
Non-invasive (DCIS, LCIS) cancer only (no diagnosis of invasive cancer)
Pregnant or lactating
Unable to speak, read, and write in English
Clareo Health | Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
